መነሻ › አቶፒክ ደርማቲቲስ (ኤክዜማ) › አርካንሳስ
በአርካንሳስ ለአቶፒክ ደርማቲቲስ (ኤክዜማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለአቶፒክ ደርማቲቲስ (ኤክዜማ) የሚደረጉ 8 ጥናቶች በአርካንሳስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአርካንሳስ ውስጥ ያሉ ከተሞች
Official study text (English)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fort Smith
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Hot Springs
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07298395A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Arkansas Research Trials, North Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 11 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Dermatology Trial Associates, Inc, Bryant
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Applied Research Center and Wellness Clinic /ID# 268547, Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 11 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, North Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 3
6 Months – 11 Years · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 63 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT06389136A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
- Arkansas Research Trials, North Little Rock
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ሴፕቴ 2025 · NCT06055361ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።